Home/Filings/4/0001213900-25-111713
4//SEC Filing

Chaudhary Zuraiz 4

Accession 0001213900-25-111713

CIK 0002023016other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 9:23 PM ET

Size

5.4 KB

Accession

0001213900-25-111713

Insider Transaction Report

Form 4
Period: 2025-11-17
Chaudhary Zuraiz
See Remarks
Transactions
  • Purchase

    Common Stock

    2025-11-17$3.62/sh+2,500$9,0507,550 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.50 to $3.69, inclusive. The Reporting Person undertakes to provide to Turn Therapeutics Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

Turn Therapeutics Inc.

CIK 0002023016

Entity typeother

Related Parties

1
  • filerCIK 0002086494

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 9:23 PM ET
Size
5.4 KB